The Limited Times

Now you can see non-English news...

Vaccines: Oxfam, whether mass or in 2021 crisis of 9 thousand billion

2021-04-06T14:07:35.692Z


Rich countries must find a road to mass production of low-cost vaccines to protect every person, in every part of the world, from COVID-19 and avert a global economic catastrophe, with losses estimated to be over 9. (ANSA )


(ANSA) - ROME, APRIL 06 - Rich countries must find a road that leads to the mass production of vaccines at low cost to protect every person from COVID-19, in every part of the world and avert a global economic catastrophe, with estimated losses up to over 9,000 billion dollars in 2021 for Italy a loss of per capita income of 1,495 dollars. This is the appeal launched on the occasion of the Spring Meetings of the International Monetary Fund and the World Bank scheduled by Oxfam, a member of the People's VaccineAlliance. Oxfam is also asking not to delay with the release of a new, albeit limited, issue of special drawing rights (SDRs) for $ 650 billion, providing extra liquidity to low- and middle-income countries in dire need. The lack of global action for mass vaccinations by advanced economies, Oxfam writes, would lead, according to the International Chamber of Commerce's most pessimistic estimates, to $ 9,200 billion in aggregate economic losses at the end of 2021, of which about half would fall. on the richest nations. According to Oxfam, the US could lose up to $ 2,700 per capita spending capacity in 2021, or about $ 1,300 more than the subsidy provided by the Biden administration, reaching a national GDP of $ 1,300 billion at the end of the year. , while Italy could record a contraction of the spent capacity per capita of 1,495 dollars; Japan of 1,451; the United Kingdom of 1,380, or about 70% of the average monthly payment envelope; France of 1,239 per capita, equivalent to the average cost of a rent; Canada of $ 1,979. (HANDLE).


Source: ansa

All life articles on 2021-04-06

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.